BACKGROUND: Tumor necrosis factor (TNF) is a key immune regulator of tuberculosis resistance, as exemplified by the highly increased risk of tuberculosis disease among individuals receiving TNF-blocker therapy. METHODS: We determined the extent of TNF production after stimulation with BCG or BCG plus interferon gamma (IFN-γ) using a whole blood assay in 392 children belonging to 135 nuclear families from an area hyperendemic for tuberculosis in South Africa. We conducted classical univariate and bivariate genome-wide linkage analysis of TNF production using the data from both stimulation protocols by means of an extension of the maximum-likelihood-binomial method for quantitative trait loci to multivariate analysis. RESULTS: Stimulation of whole blood by either BCG or BCG plus IFN-γ resulted in a range of TNF release across subjects. Extent of TNF production following both stimulation protocols was highly correlated (r = 0.81). We failed to identify genetic linkage of TNF release when considering each stimulus separately. However, using a multivariate approach, we detected a major pleiotropic locus (P < 10(-5)) on chromosome region 11p15, termed TNF locus 1 (TNF1), that controlled TNF production after stimulation by both BCG alone and BCG plus IFN-γ. CONCLUSIONS: The TNF1 locus was mapped in the vicinity of the TST1 locus, previously identified in the same family sample, that controls tuberculin skin test (TST) negativity per se, that is, T-cell-independent resistance to Mycobacterium tuberculosis infection. This suggested that there is a connection between TST negativity per se and TNF production.
BACKGROUND:Tumor necrosis factor (TNF) is a key immune regulator of tuberculosis resistance, as exemplified by the highly increased risk of tuberculosis disease among individuals receiving TNF-blocker therapy. METHODS: We determined the extent of TNF production after stimulation with BCG or BCG plus interferon gamma (IFN-γ) using a whole blood assay in 392 children belonging to 135 nuclear families from an area hyperendemic for tuberculosis in South Africa. We conducted classical univariate and bivariate genome-wide linkage analysis of TNF production using the data from both stimulation protocols by means of an extension of the maximum-likelihood-binomial method for quantitative trait loci to multivariate analysis. RESULTS: Stimulation of whole blood by either BCG or BCG plus IFN-γ resulted in a range of TNF release across subjects. Extent of TNF production following both stimulation protocols was highly correlated (r = 0.81). We failed to identify genetic linkage of TNF release when considering each stimulus separately. However, using a multivariate approach, we detected a major pleiotropic locus (P < 10(-5)) on chromosome region 11p15, termed TNF locus 1 (TNF1), that controlled TNF production after stimulation by both BCG alone and BCG plus IFN-γ. CONCLUSIONS: The TNF1 locus was mapped in the vicinity of the TST1 locus, previously identified in the same family sample, that controls tuberculin skin test (TST) negativity per se, that is, T-cell-independent resistance to Mycobacterium tuberculosis infection. This suggested that there is a connection between TST negativity per se and TNF production.
Authors: A J M de Craen; D Posthuma; E J Remarque; A H J van den Biggelaar; R G J Westendorp; D I Boomsma Journal: Genes Immun Date: 2005-03 Impact factor: 2.676
Authors: Catherine M Stein; Lorna Nshuti; Allan B Chiunda; W Henry Boom; Robert C Elston; Roy D Mugerwa; Sudha K Iyengar; Christopher C Whalen Journal: Hum Hered Date: 2005-10-13 Impact factor: 0.444
Authors: Juan Manuel Cubillos-Angulo; María B Arriaga; Elisângela C Silva; Beatriz L A Müller; Daniela M P Ramalho; Kiyoshi F Fukutani; Pryscila F C Miranda; Adriana S R Moreira; Antonio Ruffino-Netto; Jose R Lapa E Silva; Timothy R Sterling; Afrânio L Kritski; Martha M Oliveira; Bruno B Andrade Journal: Clin Infect Dis Date: 2019-08-30 Impact factor: 9.079
Authors: Julian S Peters; Jason R Andrews; Mark Hatherill; Sabine Hermans; Leonardo Martinez; Erwin Schurr; Yuri van der Heijden; Robin Wood; Roxana Rustomjee; Bavesh D Kana Journal: Lancet Infect Dis Date: 2018-12-13 Impact factor: 25.071
Authors: Javeed A Shah; Munyaradzi Musvosvi; Muki Shey; David J Horne; Richard D Wells; Glenna J Peterson; Jeffery S Cox; Michelle Daya; Eileen G Hoal; Lin Lin; Raphael Gottardo; Willem A Hanekom; Thomas J Scriba; Mark Hatherill; Thomas R Hawn Journal: Am J Respir Crit Care Med Date: 2017-08-15 Impact factor: 21.405
Authors: Javeed A Shah; Alex J Warr; Andrew D Graustein; Aparajita Saha; Sarah J Dunstan; Nguyen T T Thuong; Guy E Thwaites; Maxine Caws; Phan V K Thai; Nguyen D Bang; Tran T H Chau; Chiea Chuen Khor; Zheng Li; Martin Hibberd; Xuling Chang; Felicia K Nguyen; Carlo A Hernandez; Madison A Jones; Christopher M Sassetti; Katherine A Fitzgerald; Munyaradzi Musvosvi; Anele Gela; Willem A Hanekom; Mark Hatherill; Thomas J Scriba; Thomas R Hawn Journal: J Immunol Date: 2022-02-25 Impact factor: 5.426
Authors: Laurent Abel; Jacques Fellay; David W Haas; Erwin Schurr; Geetha Srikrishna; Michael Urbanowski; Nimisha Chaturvedi; Sudha Srinivasan; Daniel H Johnson; William R Bishai Journal: Lancet Infect Dis Date: 2017-10-27 Impact factor: 25.071
Authors: Jason D Simmons; Catherine M Stein; Chetan Seshadri; Monica Campo; Galit Alter; Sarah Fortune; Erwin Schurr; Robert S Wallis; Gavin Churchyard; Harriet Mayanja-Kizza; W Henry Boom; Thomas R Hawn Journal: Nat Rev Immunol Date: 2018-09 Impact factor: 108.555